These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18959050)

  • 1. Developing a risk assessment process for current and emerging infectious diseases.
    Eglin R
    Lijec Vjesn; 2007 May; 129 Suppl 3():5. PubMed ID: 18959050
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing emerging infectious threats to blood safety for the blood disorders community.
    Trimble SR; Parker CS; Grant AM; Soucie JM; Reyes N
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S468-74. PubMed ID: 20331945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging, re-emerging and submerging infectious threats to the blood supply.
    Alter HJ
    Vox Sang; 2004 Jul; 87 Suppl 2():56-61. PubMed ID: 15209880
    [No Abstract]   [Full Text] [Related]  

  • 4. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.
    Brooks JP
    Transfusion; 2005 Oct; 45(4 Suppl):159S-71S. PubMed ID: 16181401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging microbial threats to the United States blood supply.
    Katz LM
    Curr Opin Hematol; 2014 Nov; 21(6):509-14. PubMed ID: 25188721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging infectious threats to the blood supply.
    Dodd RY; Leiby DA
    Annu Rev Med; 2004; 55():191-207. PubMed ID: 14746517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the transmission risk of emerging infectious diseases through blood transfusion.
    Oei W; Janssen MP; van der Poel CL; van Steenbergen JE; Rehmet S; Kretzschmar ME
    Transfusion; 2013 Jul; 53(7):1421-8. PubMed ID: 23113823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blue Ribbon Committee on Bloodborne Parasitic Diseases.
    Health Canada, Bureau of Infectious Diseases, Centre for Infrectious Disease Prevention and Control
    Can Commun Dis Rep; 2002 Sep; 28 Suppl 3():1-23 (Eng), 1-27 (Fre). PubMed ID: 12845878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential threat to blood transfusion safety of emerging infectious disease agents.
    Stramer SL
    Clin Adv Hematol Oncol; 2015 Jul; 13(7):420-2. PubMed ID: 26353036
    [No Abstract]   [Full Text] [Related]  

  • 12. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging infectious disease agents and their potential threat to transfusion safety.
    Stramer SL; Hollinger FB; Katz LM; Kleinman S; Metzel PS; Gregory KR; Dodd RY
    Transfusion; 2009 Aug; 49 Suppl 2():1S-29S. PubMed ID: 19686562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion and infectious diseases].
    Hamaguchi I
    Rinsho Byori; 2013 May; 61(5):414-7. PubMed ID: 23947180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual risks of blood transfusion in Rhode Island.
    Sweeney JD; Kurtis J; Starakiewicz J
    Med Health R I; 2005 Jul; 88(7):224-5, 228-31. PubMed ID: 16184827
    [No Abstract]   [Full Text] [Related]  

  • 16. Virulence evolution in emerging infectious diseases.
    André JB; Hochberg ME
    Evolution; 2005 Jul; 59(7):1406-12. PubMed ID: 16153027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The BOTIA project ("Blood and Organ Transmissible Infectious Agents"): a European collection of blood samples and an observatory of agents transmitted by blood transfusion or organ transplantation].
    Lefrère JJ
    Transfus Clin Biol; 2005 Jun; 12(2):93-4. PubMed ID: 15894503
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging pathogens and their implications for the blood supply and transfusion transmitted infections.
    Dodd RY
    Br J Haematol; 2012 Oct; 159(2):135-42. PubMed ID: 22924410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.
    Atreya C; Nakhasi H; Mied P; Epstein J; Hughes J; Gwinn M; Kleinman S; Dodd R; Stramer S; Walderhaug M; Ganz P; Goodrich R; Tibbetts C; Asher D
    Transfusion; 2011 Aug; 51(8):1855-71. PubMed ID: 21392016
    [No Abstract]   [Full Text] [Related]  

  • 20. Cause and effect. Newly emerging infectious diseases.
    Nat Rev Microbiol; 2006 Jun; 4(6):414. PubMed ID: 16767807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.